SafeSpace Global Begins Paid Deployment of AI Safety Platform at Antidote Health Facility

  • SafeSpace Global signed a 60-month Statement of Work with Antidote Health Ventures for initial paid deployment of its Behavioral Health safety platform at a Tennessee facility.
  • The deployment follows a June 2026 Master Services Agreement and marks the first commercial implementation of SafeSpace's Addiction Treatment Vertical.
  • The platform will provide monitoring, alerting, and AI-assisted capabilities tailored for behavioral health environments.
  • Commercial pricing has been established for this initial deployment, with potential for expansion to additional facilities.

This deployment represents a strategic shift from development to commercial implementation for SafeSpace's Addiction Treatment Vertical. The partnership with Antidote Health Ventures, an early-stage company with a vertically integrated recovery model, positions SafeSpace to address distinct safety challenges in behavioral health facilities. The success of this deployment could validate the market need for AI-assisted monitoring solutions in addiction treatment environments.

Technology Refinement
How operational learnings from this deployment will inform platform improvements for behavioral health environments.
Market Expansion
Whether SafeSpace can successfully scale this solution across the addiction treatment continuum.
Commercial Viability
The pace at which this initial deployment could lead to broader commercial agreements with Antidote.